REPORTS

Let’s Pullulate and Expand Your Business

Global mRNA Vaccines & Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 09, 2020  |  173 PAGES  |  REPORT CODE: CMM332699
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The mRNA Vaccines & Therapeutics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period. The research provides insights for the global mRNA Vaccines & Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the mRNA Vaccines & Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global mRNA Vaccines & Therapeutics Market Segmentations:

By Players:

  • Moderna Therapeutics

  • eTheRNA

  • BioNTech

  • CureVac

  • In-Cell-Art

  • Translate Bio

  • Tiba Biotechnology

  • Argos Therapeutics

  • Sangamo Therapeutics

  • Ethris

By Types:

  • Standardization Of Cancer Treatment MRNA Vaccine

  • Individualized Cancer Treatment MRNA Vaccine

  • Infectious Disease Treatment MRNA Vaccine

  • Infection Prevention MRNA Vaccine

By End-User:

  • Infectious Disease

  • Cancer

  • Other

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccines & Therapeutics Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2014 to 2026

    • 1.3.2 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026

    • 1.3.3 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026

    • 1.3.4 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • 1.4.2 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Cancer from 2014 to 2026

    • 1.4.3 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Other from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of mRNA Vaccines & Therapeutics Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of mRNA Vaccines & Therapeutics by Major Types

    • 3.4.1 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

    • 3.4.2 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

    • 3.4.3 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

    • 3.4.4 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine

4 Segmentation of mRNA Vaccines & Therapeutics Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of mRNA Vaccines & Therapeutics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of mRNA Vaccines & Therapeutics in Infectious Disease

    • 4.4.2 Market Size and Growth Rate of mRNA Vaccines & Therapeutics in Cancer

    • 4.4.3 Market Size and Growth Rate of mRNA Vaccines & Therapeutics in Other

5 Market Analysis by Major Regions

  • 5.1 Global mRNA Vaccines & Therapeutics Production Analysis by Major Regions

  • 5.2 Global mRNA Vaccines & Therapeutics Consumption Analysis by Major Regions

  • 5.3 Global mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

6 Product Commodity of mRNA Vaccines & Therapeutics Market in Major Countries

  • 6.1 Top 5 Export Countries in mRNA Vaccines & Therapeutics market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

  • 6.2 Top 5 Import Countries in mRNA Vaccines & Therapeutics market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America mRNA Vaccines & Therapeutics Landscape Analysis

  • 7.1 North America mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

  • 7.2 North America mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

  • 7.3 North America mRNA Vaccines & Therapeutics Landscape Analysis by Major Countries

    • 7.3.1 United States mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 7.3.2 Canada mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 7.3.3 Mexico mRNA Vaccines & Therapeutics Market Volume and Growth Rate

8 Europe mRNA Vaccines & Therapeutics Landscape Analysis

  • 8.1 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

  • 8.2 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

  • 8.3 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Major Countries

    • 8.3.1 Germany mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.2 UK mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.3 France mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.4 Italy mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.5 Nordic Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.6 Spain mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.7 Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.8 Poland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.9 Russia mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 8.3.10 Turkey mRNA Vaccines & Therapeutics Market Volume and Growth Rate

9 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis

  • 9.1 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

  • 9.2 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis by Major Countries

    • 9.3.1 China mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 9.3.2 Japan mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 9.3.4 India mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 9.3.6 South Korea mRNA Vaccines & Therapeutics Market Volume and Growth Rate

10 Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Landscape Analysis

  • 10.1 Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 10.3.2 Brazil mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 10.3.3 Nigeria mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    • 10.3.4 South Africa mRNA Vaccines & Therapeutics Market Volume and Growth Rate 

    • 10.3.5 Argentina mRNA Vaccines & Therapeutics Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Moderna Therapeutics

    • 11.1.1 Moderna Therapeutics Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 eTheRNA

    • 11.2.1 eTheRNA Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 BioNTech

    • 11.3.1 BioNTech Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 CureVac

    • 11.4.1 CureVac Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 In-Cell-Art

    • 11.5.1 In-Cell-Art Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Translate Bio

    • 11.6.1 Translate Bio Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Tiba Biotechnology

    • 11.7.1 Tiba Biotechnology Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Argos Therapeutics

    • 11.8.1 Argos Therapeutics Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Sangamo Therapeutics

    • 11.9.1 Sangamo Therapeutics Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Ethris

    • 11.10.1 Ethris Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 123 Figures and 200 Tables)

  • Figure Product Picture

  • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2014 to 2026

  • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026

  • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026

  • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease from 2014 to 2026

  • Figure Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Cancer from 2014 to 2026

  • Figure Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Other from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of mRNA Vaccines & Therapeutics Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of mRNA Vaccines & Therapeutics

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

  • Table Consumption Share of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

  • Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

  • Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

  • Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

  • Table Consumption Share of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Infectious Disease

  • Figure Market Size and Growth Rate of Cancer

  • Figure Market Size and Growth Rate of Other

  • Table Global mRNA Vaccines & Therapeutics Production by Major Regions

  • Table Global mRNA Vaccines & Therapeutics Production Share by Major Regions

  • Figure Global mRNA Vaccines & Therapeutics Production Share by Major Regions in 2014

  • Figure Global mRNA Vaccines & Therapeutics Production Share by Major Regions in 2018

  • Figure Global mRNA Vaccines & Therapeutics Production Share by Major Regions in 2026

  • Table Global mRNA Vaccines & Therapeutics Consumption by Major Regions

  • Table Global mRNA Vaccines & Therapeutics Consumption Share by Major Regions

  • Figure Global mRNA Vaccines & Therapeutics Consumption Share by Major Regions in 2014

  • Figure Global mRNA Vaccines & Therapeutics Consumption Share by Major Regions in 2018

  • Figure Global mRNA Vaccines & Therapeutics Consumption Share by Major Regions in 2026

  • Table North America mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

  • Table Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

  • Table Asia Pacific mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines & Therapeutics market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

  • Table North America mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Types in 2014

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Types in 2018

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Types in 2026

  • Table North America mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

  • Table North America mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2014

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2018

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2026

  • Table North America mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2014

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2018

  • Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2026

  • Figure United States mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Europe mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

  • Table Europe mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by Types in 2014

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by Types in 2018

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by Types in 2026

  • Table Europe mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

  • Table Europe mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2014

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2018

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2026

  • Table Europe mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table Europe mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2014

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2018

  • Figure Europe mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2026

  • Figure Germany mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure UK mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure France mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

  • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Types in 2014

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Types in 2018

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Types in 2026

  • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2014

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2018

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2026

  • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2014

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2018

  • Figure Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2026

  • Figure China mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandmRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure India mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2026

  • Figure GCC Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Moderna Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

  • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

  • Figure Revenue and Market Share Analysis of Moderna Therapeutics

  • Table Product and Service Introduction of Moderna Therapeutics

  • Table Company Profile and Development Status of eTheRNA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA

  • Figure Sales and Growth Rate Analysis of eTheRNA

  • Figure Revenue and Market Share Analysis of eTheRNA

  • Table Product and Service Introduction of eTheRNA

  • Table Company Profile and Development Status of BioNTech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech

  • Figure Sales and Growth Rate Analysis of BioNTech

  • Figure Revenue and Market Share Analysis of BioNTech

  • Table Product and Service Introduction of BioNTech

  • Table Company Profile and Development Status of CureVac

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac

  • Figure Sales and Growth Rate Analysis of CureVac

  • Figure Revenue and Market Share Analysis of CureVac

  • Table Product and Service Introduction of CureVac

  • Table Company Profile and Development Status of In-Cell-Art

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art

  • Figure Sales and Growth Rate Analysis of In-Cell-Art

  • Figure Revenue and Market Share Analysis of In-Cell-Art

  • Table Product and Service Introduction of In-Cell-Art

  • Table Company Profile and Development Status of Translate Bio

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Translate Bio

  • Figure Sales and Growth Rate Analysis of Translate Bio

  • Figure Revenue and Market Share Analysis of Translate Bio

  • Table Product and Service Introduction of Translate Bio

  • Table Company Profile and Development Status of Tiba Biotechnology

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiba Biotechnology

  • Figure Sales and Growth Rate Analysis of Tiba Biotechnology

  • Figure Revenue and Market Share Analysis of Tiba Biotechnology

  • Table Product and Service Introduction of Tiba Biotechnology

  • Table Company Profile and Development Status of Argos Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics

  • Figure Sales and Growth Rate Analysis of Argos Therapeutics

  • Figure Revenue and Market Share Analysis of Argos Therapeutics

  • Table Product and Service Introduction of Argos Therapeutics

  • Table Company Profile and Development Status of Sangamo Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics

  • Figure Sales and Growth Rate Analysis of Sangamo Therapeutics

  • Figure Revenue and Market Share Analysis of Sangamo Therapeutics

  • Table Product and Service Introduction of Sangamo Therapeutics

  • Table Company Profile and Development Status of Ethris

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris

  • Figure Sales and Growth Rate Analysis of Ethris

  • Figure Revenue and Market Share Analysis of Ethris

  • Table Product and Service Introduction of Ethris


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top